Yingdong Lu

1.5k total citations · 2 hit papers
28 papers, 871 citations indexed

About

Yingdong Lu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yingdong Lu has authored 28 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yingdong Lu's work include Traditional Chinese Medicine Analysis (4 papers), Cardiac Fibrosis and Remodeling (4 papers) and Cancer-related molecular mechanisms research (3 papers). Yingdong Lu is often cited by papers focused on Traditional Chinese Medicine Analysis (4 papers), Cardiac Fibrosis and Remodeling (4 papers) and Cancer-related molecular mechanisms research (3 papers). Yingdong Lu collaborates with scholars based in China and United States. Yingdong Lu's co-authors include Xiangning Cui, Mi Xiang, Chang Shang, Laiyun Xin, Yuling Wang, Hongchen Lin, Yi Qu, Zihuan Shen, Jialiang Gao and Mingjing Zhao and has published in prestigious journals such as PLoS ONE, Cancer Research and Archives of Biochemistry and Biophysics.

In The Last Decade

Yingdong Lu

24 papers receiving 858 citations

Hit Papers

Role of Oxidative Stress in Reperfusion following Myocard... 2021 2026 2022 2024 2021 2024 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingdong Lu China 15 462 150 136 117 109 28 871
Qiao Yang China 19 484 1.0× 220 1.5× 174 1.3× 131 1.1× 93 0.9× 48 1.1k
Xiaoyi Bao China 19 450 1.0× 108 0.7× 108 0.8× 114 1.0× 64 0.6× 26 911
Jiagen Wen China 19 515 1.1× 93 0.6× 117 0.9× 145 1.2× 108 1.0× 47 1.1k
Jing Zong China 22 503 1.1× 248 1.7× 125 0.9× 154 1.3× 103 0.9× 51 1.2k
Nelly Étienne-Selloum France 20 449 1.0× 82 0.5× 79 0.6× 135 1.2× 75 0.7× 33 1.1k
Minglu Liang China 20 441 1.0× 104 0.7× 75 0.6× 185 1.6× 64 0.6× 52 884
Zheng Xu China 18 488 1.1× 178 1.2× 75 0.6× 86 0.7× 60 0.6× 35 1.1k
Jiali Wang China 20 541 1.2× 185 1.2× 130 1.0× 106 0.9× 228 2.1× 62 1.1k
Xin Han China 20 460 1.0× 54 0.4× 101 0.7× 96 0.8× 124 1.1× 59 1.1k
Gaojun Wu China 19 680 1.5× 296 2.0× 94 0.7× 130 1.1× 60 0.6× 64 1.3k

Countries citing papers authored by Yingdong Lu

Since Specialization
Citations

This map shows the geographic impact of Yingdong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingdong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingdong Lu more than expected).

Fields of papers citing papers by Yingdong Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingdong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingdong Lu. The network helps show where Yingdong Lu may publish in the future.

Co-authorship network of co-authors of Yingdong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yingdong Lu. A scholar is included among the top collaborators of Yingdong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingdong Lu. Yingdong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xiangchun, et al.. (2025). Naringin in repairing articular cartilage injury by activating TGF-β/Smad signaling pathway to attenuate inflammatory response. Archives of Biochemistry and Biophysics. 768. 110396–110396.
2.
Lu, Yingdong, Aling Shen, Daxin Chen, et al.. (2024). Dehydrocorydaline attenuates myocardial ischemia-reperfusion injury via the FoXO signalling pathway: A multimodal study based on network pharmacology, molecular docking, and experimental study. Journal of Ethnopharmacology. 337(Pt 1). 118738–118738. 5 indexed citations
4.
Liu, Ying, Yingdong Lu, Zehui Chen, et al.. (2024). Identification of potential biomarkers for lung adenocarcinoma: a study based on bioinformatics analysis combined with validation experiments. Frontiers in Oncology. 14. 1425895–1425895.
5.
Wang, Yuling, Chen Chen, Zihuan Shen, et al.. (2024). The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms. Biomedicine & Pharmacotherapy. 171. 116116–116116. 45 indexed citations breakdown →
6.
Xiang, Mi, Xin Zhao, Yingdong Lu, et al.. (2023). Modified Linggui Zhugan Decoction protects against ventricular remodeling through ameliorating mitochondrial damage in post-myocardial infarction rats. Frontiers in Cardiovascular Medicine. 9. 1038523–1038523. 4 indexed citations
7.
Cui, Xiangning, Yang Zhang, Yingdong Lu, & Mi Xiang. (2022). ROS and Endoplasmic Reticulum Stress in Pulmonary Disease. Frontiers in Pharmacology. 13. 879204–879204. 43 indexed citations
8.
Lu, Yingdong, Mi Xiang, Laiyun Xin, et al.. (2022). Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure. Frontiers in Pharmacology. 13. 905424–905424. 16 indexed citations
9.
Lu, Yingdong, Yang Zhang, Xin Zhao, et al.. (2022). Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease. Frontiers in Cardiovascular Medicine. 9. 900381–900381. 56 indexed citations
10.
Shang, Chang, Laiyun Xin, Mi Xiang, et al.. (2022). Regulatory mechanism of icariin in cardiovascular and neurological diseases. Biomedicine & Pharmacotherapy. 158. 114156–114156. 21 indexed citations
11.
Zhang, Yang, Laiyun Xin, Mi Xiang, et al.. (2021). The molecular mechanisms of ferroptosis and its role in cardiovascular disease. Biomedicine & Pharmacotherapy. 145. 112423–112423. 116 indexed citations
12.
Xiang, Mi, Yingdong Lu, Laiyun Xin, et al.. (2021). Role of Oxidative Stress in Reperfusion following Myocardial Ischemia and Its Treatments. Oxidative Medicine and Cellular Longevity. 2021(1). 6614009–6614009. 190 indexed citations breakdown →
13.
Shang, Chang, Hongchen Lin, Yuling Wang, et al.. (2021). Beneficial effects of cinnamon and its extracts in the management of cardiovascular diseases and diabetes. Food & Function. 12(24). 12194–12220. 66 indexed citations
14.
Xin, Laiyun, Jialiang Gao, Hongchen Lin, et al.. (2020). Regulatory Mechanisms of Baicalin in Cardiovascular Diseases: A Review. Frontiers in Pharmacology. 11. 583200–583200. 64 indexed citations
15.
Cao, Jay, et al.. (2020). Analytical Visual Methods to Describe Practice Patterns in a Newly Diagnosed Multiple Myeloma Non-Interventional Disease Registry. Journal of Biometrics & Biostatistics. 11(2). 1–4. 1 indexed citations
16.
Lu, Yingdong, Zhilin Jiang, Dandan Zhang, et al.. (2020). Guanxinshutong Alleviates Atherosclerosis by Suppressing Oxidative Stress and Proinflammation in ApoE−/− Mice. Evidence-based Complementary and Alternative Medicine. 2020(1). 1219371–1219371. 6 indexed citations
18.
Lian, Hong, Xiaojian Wang, Juan Wang, et al.. (2015). Heart-specific overexpression of (pro)renin receptor induces atrial fibrillation in mice. International Journal of Cardiology. 184. 28–35. 18 indexed citations
19.
Lü, Dan, Li Zhang, Dan Bao, et al.. (2014). Calponin1 inhibits dilated cardiomyopathy development in mice through the εPKC pathway. International Journal of Cardiology. 173(2). 146–153. 17 indexed citations
20.
Ma, Yuanwu, Bin Shen, Xu Zhang, et al.. (2014). Heritable Multiplex Genetic Engineering in Rats Using CRISPR/Cas9. PLoS ONE. 9(3). e89413–e89413. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026